6Zheng W, Warner R, Ruggeri R, et al. PF-1355, a mecha- nism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulone- phritis [J]. J Pharmacol Exp Ther,2015,353(2):288-298.
7Amirshahrokhi K, Khalili AR. The effect of thalidomide on etha- nol-induced gastric mucosal damage in mice: involvement of in- flammatory cytokines and nitric oxide [J]. Chem Biol Interact,2015, 225:63-69.
8Hatemi I, Hatemi G, Pamuk ON, et al. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behqet's syn- drome refractory to the conventional treatment modalities: a case series and review of the literature [J]. Clin Exp Rheumatol,2015,33 (6):S129-137.
9Wan P, Zhao X, Hunasehally RY, et al. Propyhhiouracil-induced ANCA-positive erythema nodosum treated with thalidomide [J]. Int J Dermatol,2012,51 (3):345-348.
10Lim YK, Keating JP, Steele R. Sucessful use of thalidomide in se- vere gastrointestinal Behqet's disease [J]. ANZ J Surg,2015,85(6): 496.
